HLA antigens in Japanese patients with systemic lupus erythematosus. 1994

H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
Department of Internal Medicine and Rheumatology, Jutendo University, Tokyo, Japan.

To determine the association of HLA antigens with SLE and the clinical findings of the disease, HLA antigens were tested in 58 Japanese patients with SLE, who fulfilled the ARA diagnostic criteria, along with 97 normal controls. HLA class I and II antigens were typed serologically using the antisera provided by the 11th HLA Workshop. Among the HLA class II antigens, further DRB, DQ and DP alleles were defined by DNA typing using the PCR/SSOP method. There were significantly more SLE patients with HLA-B39, DRB1*1501, DRB5*0101 and DQB1*0602 than normal controls. This result suggested that the haplotype of HLA-DRB1*1501-DRB5*0101-DQA1*0102-DQB1*0602 consists of the SLE-associated MHC markers in Japan. There were some positive and negative associations between the HLA antigens and clinical or serological findings in SLE. There is a possibility that some HLA alleles might be related to the clinical and/or serological subsets of SLE.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
January 1984, Terapevticheskii arkhiv,
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
October 1994, Lupus,
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
February 1977, Annals of the rheumatic diseases,
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
September 1982, Tissue antigens,
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
January 1984, Revista do Hospital das Clinicas,
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
May 1979, Archives of dermatological research,
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
October 1985, The Journal of rheumatology,
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
January 1985, Revmatologiia (Moscow, Russia),
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
January 1985, Terapevticheskii arkhiv,
H Hashimoto, and Y Nishimura, and R P Dong, and A Kimura, and T Sasazuki, and K Yamanaka, and Y Tokano, and A Murashima, and K Kabasawa, and S Hirose
November 2001, Rheumatology international,
Copied contents to your clipboard!